XPF mediates 3′ flap processing for FEN1-independent Okazaki fragment maturation
Nucleic Acids Research · 20.05.2026 · 54 (10)
DOI: 10.1093/nar/gkag536 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nucleic Acids Research, online erschienen am 26.05.2026. Verfasst von Kejiao Li und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cancer Genetics and Epigenetics, City of Hope Beckman Research Institute, Duarte, CA 91010, United States. Hauptthemen laut MEDLINE: Flap Endonucleases, DNA-Binding Proteins, DNA. Die Arbeit nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, Chinese Academy of Medical Sciences, National Cancer Institute.
Abstract (Originalsprache)
Okazaki fragment maturation (OFM), the process that removes RNA-DNA primers, is a major source of DNA replication stress and mutations. It involves Polδ-mediated DNA strand displacement synthesis that produces 5′ flaps, FEN1-mediated 5′ flap cleavage, and LIG1-catalyzed nick ligation. Recently, we discovered that under hyperthermal stress conditions, yeast cells convert 5′ flaps into 3′ flaps, which are degraded by 3′ flap nucleases to produce DNA nicks. However, little is known about this 3′ flap-based OFM in human cells. Here, we report that 3′ flaps frequently form in various human cancer cells, and that FEN1 deficiency significantly enhances 3′ flap levels. XPF1 is recruited to the replication forks in FEN1 mutant or FEN1-chemically inhibited cells. Notably, XPF deficiency or inhibition in those defective cells leads to accumulation of 3′ flaps, replication-related DNA strand breaks, and unique mutation signatures. Furthermore, XPF and FEN1 inhibitors show synergistic effects in killing human cancer cells. In summary, we demonstrate that 3′ flap-based OFM is an important alternative of 5′ flap-based OFM in mammalian cells. XPF is a key nuclease to degrade 3′ flaps and complete OFM for survival. Targeting this compensatory mechanism could provide new therapeutic strategies to selectively impair cancer cell survival under replication stress.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Cancer Genetics and Epigenetics, City of Hope Beckman Research Institute, Duarte, CA 91010, United States.
- InnoHK Center for Neuromusculoskeletal Restorative Medicine Limited, Hong Kong Science Park, Hong Kong SAR 999077, China.
- Medicinal Plant Resources and Protection Research Center, Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing 100193, China.
ORCID-Profile: Li Zheng, Binghui Shen
Förderung
- NCI NIH HHS
- Chinese Academy of Medical Sciences
- National Cancer Institute
Zitieren
APA
Li, K., Yang, F., Wang, Y., Shi, G., Wang, Y., Liu, Y., Yan, Y., Lei, Y., Zhou, M., Sun, H., Zheng, L., & Shen, B. (2026). XPF mediates 3′ flap processing for FEN1-independent Okazaki fragment maturation. Nucleic Acids Research, 54(10). https://doi.org/10.1093/nar/gkag536
Vancouver
Li K, Yang F, Wang Y, Shi G, Wang Y, Liu Y, et al. XPF mediates 3′ flap processing for FEN1-independent Okazaki fragment maturation. Nucleic Acids Research. 2026;54(10). doi:10.1093/nar/gkag536
BibTeX
@article{Li2026,
author = {Li, Kejiao and Yang, Feng and Wang, Yingying and Shi, Guojun and Wang, Yixing and Liu, Yunhao and Yan, Yao and Lei, Yi and Zhou, Main and Sun, Haitao and Zheng, Li and Shen, Binghui},
title = {XPF mediates 3′ flap processing for FEN1-independent Okazaki fragment maturation},
journal = {Nucleic Acids Research},
year = {2026},
volume = {54},
number = {10},
doi = {10.1093/nar/gkag536}
}
EUVIMED